Archive

  • A de-SPAC to Dodge

    G Squared Equity Management L.P. is an investment adviser whose affiliates have sponsored two SPACs: G Squared Ascend I Inc. (NYSE:GSQD) and G Squared Ascend II Inc. (NYSE:GSQB). In dual IPOs last year, the blank-check companies raised $300,000,000 and $125,000,000, respectively, on the promise that their shared management team–which also manages G Squared Equity Management–would […]

    To access this post, you must purchase a Monthly Subscription or Annual Subscription.

    Read more


  • Arcadia Biosciences Rises on Wheat Hype

    Just a month ago, Arcadia Biosciences, Inc. (NASDAQ:RKDA) was a penny stock in danger of delisting. But over the past three weeks, the stock has delivered a series of one-day gains as high as 31%. Today, it closed up 34% at $2.62 per share, its highest price since last July. What’s driving the rally? Maybe […]

    To access this post, you must purchase a Monthly Subscription or Annual Subscription.

    Read more


  • Someone Is Smoking INDO

    News of a potential ban on Russian oil in the U.S. on Monday led to a rally in nearly every small-cap stock remotely related to oil. The darling of the bunch was Indonesia Energy Corporation Ltd. (NYSEAMERICAN: INDO), which is the latest battleground stock of self-styled retail apes. A month ago, it was hovering around $4.30 per share. Yesterday, it closed at $61.50. Here’s why it won’t cruise at that altitude for long.

    To access this post, you must purchase a Monthly Subscription or Annual Subscription.

    Read more


  • Mysterious Price Action in Shares of Datasea, Inc.

    Last month around Valentine’s Day, someone fell in love with Datasea, Inc. (NASDAQ:DTSS). The company’s stock price, which had been declining since Jul. 2021, suddenly sprang to life on Feb. 10, 2022. Over the following 12 days, the price rose 81% to $2.64 per share.

    To access this post, you must purchase a Monthly Subscription or Annual Subscription.

    Read more


  • Vallon Pharmaceuticals Gets Ahead of Itself

    Riddle us this: which stock’s price climbed 85% in the past month while every major market index was nosediving? You’re right if you answered Vallon Pharmaceuticals, Inc. (NASDAQ:VLON), which closed down 2% at $7.86 per share last Friday. The greater riddle, however, is what caused the stock’s remarkable run.

    Read more


  • A Singular Diluter

    Shares of Singularity Future Technology Ltd. (NASDAQ:SGLY) more than doubled in price during the past three weeks before closing down 9.9% at $6.46 per share last Friday. At no time before or during the rally was any earth-shattering news about the company released.

    To access this post, you must purchase a Monthly Subscription or Annual Subscription.

    Read more


  • How Warrants Work

    A warrant gives its owner the right to order a company to issue a new share. In addition, it gives the owner the right to buy the newly issued share at a predetermined price. If the issuer has registered the underlying share with the SEC, the owner can immediately sell the newly issued share on […]

    Read more


  • BIMI International Medical, Inc. Is in a Death Spiral

    A stock priced at $1.73 per share doesn’t often make an attractive short sale. When it does, the price is usually headed toward zero. Such is the case, in our opinion, with shares of BIMI International Medical, Inc. (NASDAQ:BIMI). We believe the company has entered a classic death spiral.

    To access this post, you must purchase a Monthly Subscription or Annual Subscription.

    Read more


  • How Dilution Works

    Dilution is commonly misunderstood by beginning and even intermediate investors. Yet it can have a major impact on the price of a small- or micro-cap stock. The phenomenon occurs when a company issues additional shares, which increases its total shares outstanding. Dilution is commonly misunderstood by beginning and even intermediate investors. Yet it can have […]

    Read more


  • Shares of TSR, Inc. Soar while Company Has ATM Offering

    While the major indices have nosedived, shares of TSR, Inc. (NASDAQ:TSRI) have climbed 58% year-to-date to close at $14.36 today. We believe the higher this stock soars, the further it will fall.

    To access this post, you must purchase a Monthly Subscription or Annual Subscription.

    Read more


  • Dilution Will Afflict Shares of G Medical Innovations Holdings Ltd.

    Shares of G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) rocketed up 280% in the past month, rising from a record low close of $1.61 on Dec. 29, 2021 to a record high close of $6.12 on Jan. 19, 2022. Although the price has since dropped to as low as $4.18, we believe it has further to fall.

    To access this post, you must purchase a Monthly Subscription or Annual Subscription.

    Read more


  • Aspire Capital Partners

    Aspire Capital Partners, LLC occupies a specialized niche among investment firms that finance capital-intensive companies. Along with Lincoln Park Capital, LLC, Aspire accounts for over 90% of the equity lines of credit extended to small-cap issuers in the U.S.

    Read more


  • Alpha Capital Anstalt

    Alpha Capital Anstalt has earned a reputation as one of the world’s most prolific and ruthless investors in cash-starved small-cap companies. Its stock-in-trade are bridge loans and private investments in public equity (PIPE) on terms that are highly unfavorable to desperate issuers. Its favorite instruments are convertible promissory notes, convertible preferred shares, and warrants with anti-dilution provisions and registration rights.

    Read more


  • Masters of Dilution

    During the quiet week between Christmas and New Year’s Eve of 2020, two little-known companies completed a reverse merger that attracted little attention. The acquirer, Ameri Holdings, Inc., was an obscure tech company in Alpharetta, Ga. The acquiree, Jay Pharma, Inc., was a privately held startup developing cannabis-based pharmaceuticals in Toronto.

    Read more